ANAPC1P5

Across TCGA pan-cancer cohorts, ANAPC1P5 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of ANAPC1P5’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where ANAPC1P5 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ANAPC1P5 is over-expressed in tumor.

LUAD, KIRC, and ESCA are the cancer types where ANAPC1P5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ANAPC1P5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	IV	+0.210	.008	4	view →
KIRC	Male	IV	+0.062	.008	3	view →
ESCA	All	II,III,IV	+0.095	.024	2	view →
LIHC	All	All	+0.007	.043	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

ANAPC1P5–LUAD

Open the LUAD breakdown →